Cargando…
COVID-19 in Liver Transplant Recipients
BACKGROUND AND AIMS: Coronavirus disease 2019 (COVID-19) has infected over 93 million people worldwide as of January 14, 2021. Various studies have gathered data on liver transplant patients infected with COVID-19. Here, we discuss the presentation of COVID-19 in immunosuppressed patients with prior...
Autores principales: | Kullar, Ravina, Patel, Ankur Prakash, Saab, Sammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369016/ https://www.ncbi.nlm.nih.gov/pubmed/34447684 http://dx.doi.org/10.14218/JCTH.2020.00098 |
Ejemplares similares
-
Diminishing Use of Liver Biopsy among Liver Transplant Recipients for Hepatitis C
por: Aby, Elizabeth, et al.
Publicado: (2017) -
Elimination of Hepatitis C in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2018) -
Curing Hepatitis C in Liver Transplant Recipients Is Associated with Changes in Immunosuppressant Use
por: Saab, Sammy, et al.
Publicado: (2016) -
Clinical Food Addiction Is Not Associated with Development of Metabolic Complications in Liver Transplant Recipients
por: Saab, Sammy, et al.
Publicado: (2017) -
Routine Laboratory Blood Tests May Diagnose Significant Fibrosis in Liver Transplant Recipients with Chronic Hepatitis C: A 10 Year Experience
por: Sheen, Victoria, et al.
Publicado: (2016)